HomeAmgen dives deeper into rare disease drugs with $27.8 billion Horizon dealFILE PHOTO: An Amgen sign is seen at the company’s

FILE PHOTO: An Amgen sign is seen at the company’s

FILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco, California October 21, 2013. The biopharmaceutical company reports earnings on Tuesday. REUTERS/Robert Galbraith/File Photo

How Trump’s Pentagon pick Hegseth fell out of love with the U.S. military

November 15, 2024

Palantir shares rally to fresh record on plans for move to Nasdaq

November 15, 2024

EV companies, battery makers urge Trump not to kill vehicle tax credits

November 15, 2024

Musk expands lawsuit against OpenAI, adding Microsoft and antitrust claims

November 15, 2024

FILE PHOTO: An Amgen sign is seen at the company’s

Most Read

How Trump’s Pentagon pick Hegseth fell out of love with the U.S. military

Palantir shares rally to fresh record on plans for move to Nasdaq

EV companies, battery makers urge Trump not to kill vehicle tax credits

Musk expands lawsuit against OpenAI, adding Microsoft and antitrust claims

EDITOR PICKS

How Trump’s Pentagon pick Hegseth fell out of love with the U.S. military

Palantir shares rally to fresh record on plans for move to Nasdaq

EV companies, battery makers urge Trump not to kill vehicle tax credits

POPULAR POSTS

How Trump’s Pentagon pick Hegseth fell out of love with the U.S. military

Palantir shares rally to fresh record on plans for move to Nasdaq

EV companies, battery makers urge Trump not to kill vehicle tax credits

POPULAR CATEGORY